Perseverance Asset Management International Legend Biotech Corp Transaction History

Perseverance Asset Management International

$844 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$41.14 - $56.98 $318,547 - $441,196	-7,743 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $273,475 - $391,587	-7,745 Reduced 50.01%	7,743 $391,000
Q1 2021 May 17, 2021	BUY	$23.55 - $32.4 $364,742 - $501,811	15,488 New	15,488 $449,000

Others Institutions Holding LEGN

# of Institutions

225

Shares Held

74.3M

Call Options Held

279K

Put Options Held

350K

Price T Rowe Associates Inc Baltimore, MD

11.2M
Shares

$366 Million
0.06% of portfolio
Ra Capital Management, L.P. Boston, MA

7.51M
Shares

$246 Million
5.1% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

6.64M
Shares

$218 Million
7.41% of portfolio
Black Rock Inc. New York, NY

5.72M
Shares

$188 Million
0.01% of portfolio
Westfield Capital Management CO LP Boston, MA

5.04M
Shares

$165 Million
1.16% of portfolio

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perseverance Asset Management International, based on Form 13F filings with the SEC.

News

Stay updated on Perseverance Asset Management International with notifications on news.

Account